Fintel reports that on February 18, 2025, Barclays downgraded their outlook for Moderna (NasdaqGS:MRNA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 78.68% Upside As of February 18 ...

Barclays is strengthening its corporate banking franchise in Asia-Pacific and the Middle East with two senior appointments in ...

Barclays is under investigation for potentially breaking anti-money laundering rules in a fresh setback for the bank. On Thursday, the bank said the Financial Conduct Authority (FCA) was examining ...

British bank Barclays posted a rise in full-year pre-tax profit that came in just ahead of analyst expectations, while also launching a £1 billion share buyback. Pretax profit rose by 24% to £8. ...

Fintel reports that on February 10, 2025, Barclays upgraded their outlook for Agilent Technologies (NYSE:A) from Underweight ...

LONDON, Feb 13 (Reuters) - Barclays (BARC.L), opens new tab raised its 2025 performance targets on Thursday after reporting a better than expected 24% rise in annual pretax profit driven by ...

Barclays shares have climbed slightly more than 9% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $14.54, more than doubling in the last 12 months.

Barclays 42nd Annual Industrial Select Conference February 19, 2025 9:15 AM ETCompany ParticipantsPaul Jacobson - ...

Barclays Plc is granting thousands of staffers almost £50 million ($63 million) of stock awards in order to more closely link their performance to the bank’s share price. The special grants ...

Barclays said it met its performance targets for 2024, including a return on tangible equity (RoTe) of 10.5% in line with guidance for greater than 10%. Return on equity is a key measure of ...